3/16
04:45 pm
atra
Atara Biotherapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Atara Biotherapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
3/16
04:05 pm
atra
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress
Medium
Report
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress
3/12
08:05 am
atra
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
High
Report
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
3/3
08:23 am
atra
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel [Yahoo! Finance]
High
Report
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel [Yahoo! Finance]
3/3
08:05 am
atra
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
High
Report
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
2/23
08:00 am
atra
Atara Biotherapeutics Provides a Business Update
Low
Report
Atara Biotherapeutics Provides a Business Update
2/12
06:56 pm
atra
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
2/3
01:33 pm
atra
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
1/29
10:00 am
atra
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
1/27
12:47 pm
atra
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
1/22
10:00 am
atra
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
1/20
01:13 pm
atra
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
1/13
03:57 pm
atra
Atara Biotherapeutics (NASDAQ:ATRA) was given a new $6.00 price target on by analysts at New Street Research.
Low
Report
Atara Biotherapeutics (NASDAQ:ATRA) was given a new $6.00 price target on by analysts at New Street Research.
1/13
10:58 am
atra
Atara Biotherapeutics (NASDAQ:ATRA) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $6.00 price target on the stock.
High
Report
Atara Biotherapeutics (NASDAQ:ATRA) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $6.00 price target on the stock.
12/19
08:44 am
atra
Atara Biotherapeutics (NASDAQ:ATRA) was given a new $25.00 price target on by analysts at Canaccord Genuity Group Inc..
Medium
Report
Atara Biotherapeutics (NASDAQ:ATRA) was given a new $25.00 price target on by analysts at Canaccord Genuity Group Inc..